drugset / Trial / NCT00832624
The Effect of Sitagliptin in Type 2 Diabetes Mellitus With Inadequate Glycemic Control (MK0431-118)
Non-randomizedSingle-groupOpen-labelTreatment
Summary
to assess the effect of treatment with Sitagliptin (MK0431) on HbA1c (Hemoglobin A1c) and the safety and tolerability of Sitagliptin.
Timeline
- Start
- 2008-11-26
- Primary completion
- 2009-09-02
- Completion
- 2009-09-02
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Sitagliptin | Small molecule | 100 mg | — |